Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial

NCT02661477 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Rhinovirus Infection

Interventions

DRUG: pegylated interferon alfa 2
OTHER: Placebo

Sponsor

Turku University Hospital